IRCT20200316046786N1已完成3 期
Effectiveness of verapamil compare with verapamil and vacuum in the treatment of Peyronie's disease
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- Male
入选标准
- •All patient have peyronie's disease at least 6 months
- •All patient have 90 c curvature in penis.
排除标准
- •Patient have plaque in all part of penis
- •patient have ventral curvature.
- •patient have erection dysfunction with peyronie disease that have not respond to oral agent or ICI.
研究者
相似试验
招募中
Unknown
The therapeutic effect of verapamil and triamcinolone along with macroneedling in the treatment of Peyronie's plaquePeyronie's plaque.N48.6Peyronie's diseaseIRCT20230408057854N1Shahid Beheshti University of Medical Sciences64
尚未招募
4 期
verapamil use in treatment of type 2 diabetes mellitus with cardiac comorbiditiesCTRI/2024/04/065649SRM College of Pharmacy
已完成
不适用
Verapamil effect on refractory epilepsy treatmentepilepsy.Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizuresIRCT2012121711778N1Shiraz University of Medical Science20
尚未招募
不适用
EN: Which drug prevents worsening of paroxysmal atrial fibrillation: verapamil or metoprolol?NL: Welk medicijn voorkomt het hardnekkiger worden van paroxismaal atriumfibrilleren: verapamil of metoprolol?NL-OMON27565Martini ziekenhuis Groningen200
撤回
4 期
Effects of VERApamil versus metoprolol to prevent progression from Paroxysmal to persistent Atrial Fibrillatioatrial fibrillationNL-OMON44431Martini Ziekenhuis200